Health
Baricitinib drug can reduce mortality in patients with moderate to severe COVID-19 – News-Medical.Net
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research…
Reviewed by Emily Henderson, B.Sc.Nov 16 2020
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden.
The findings, published in the journal Science Advances, support the continuation of ongoing randomized clinical trials.
“We are pleased to report a 71 percent reduction in mortality for the group…
-
General23 hours agoDairy farmers devastated by floods across parts of New South Wales
-
Noosa News21 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
Noosa News23 hours agoMan dies in Gold Coast after rolling trailer pins him to lamp-post
-
General17 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank